N-((1-(3,4-difluorophenyl)-1H-tetrazol-5-yl)methyl)-1-(3,4-dimethylphenyl)-5-oxopyrrolidine-3-carboxamide结构式
|
常用名 | N-((1-(3,4-difluorophenyl)-1H-tetrazol-5-yl)methyl)-1-(3,4-dimethylphenyl)-5-oxopyrrolidine-3-carboxamide | 英文名 | N-((1-(3,4-difluorophenyl)-1H-tetrazol-5-yl)methyl)-1-(3,4-dimethylphenyl)-5-oxopyrrolidine-3-carboxamide |
|---|---|---|---|---|
| CAS号 | 1005306-61-5 | 分子量 | 426.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H20F2N6O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-((1-(3,4-difluorophenyl)-1H-tetrazol-5-yl)methyl)-1-(3,4-dimethylphenyl)-5-oxopyrrolidine-3-carboxamide |
|---|
| 分子式 | C21H20F2N6O2 |
|---|---|
| 分子量 | 426.4 |
| InChIKey | PXPNAIMZECLEJW-UHFFFAOYSA-N |
| SMILES | Cc1ccc(N2CC(C(=O)NCc3nnnn3-c3ccc(F)c(F)c3)CC2=O)cc1C |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|